Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,206.80
Bid: 1,206.60
Ask: 1,206.80
Change: -2.00 (-0.17%)
Spread: 0.20 (0.02%)
Open: 1,216.80
High: 1,222.20
Low: 1,204.80
Yest. Close: 1,208.80
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

U.S. government taps GlaxoSmithKline for new antibiotics

LONDON, May 22 (Reuters) - The U.S. government has signed an antibiotics development deal worth up to $200 million with GlaxoSmithKline to tackle the dual threats of drug resistance and bioterrorism. The collaboration, the first of its kind between Washington and a drug company, will allow

22 May 13 11:01

Wednesday broker round-up UPDATE

Afferro Mining: Panmure Gordon reduces target price from 279p to 100p, while keeping its buy recommendation. Amara Mining: Westhouse Securities cuts target price from 110p to 90p retaining a buy recommendation. Amlin: Westhouse Securities moves target price from 455p to 470p and upgrades to add.

22 May 13 09:37

Immune system cancer drugs tipped to be a $35 bln market

* Potential sales of $35 bln a year over next 10 years - Citigroup * Immunotherapy may be used in up to 60 percent of cancers * Bristol-Myers Squibb and Roche both upgraded to "buy" By Ben Hirschler LONDON, May 22 (Reuters) - A new wave of medicines that tap the power of t

22 May 13 09:33

UPDATE 3-Royalty raises Elan bid, issues ultimatum to shareholders

* Bid raised to $12.50/share from $11.25 * Royalty will withdraw bid if shareholders back Elan deals * Reserves right to cut acceptance threshold to 50 pct By Padraic Halpin and Jessica Toonkel DUBLIN/NEW YORK, May 20 (Reuters) - Royalty Pharma raised its hostile bid for

20 May 13 19:27

UPDATE 3-XenoPort to drop multiple sclerosis drug, shares fall

* Drug does not show statistical significance compared with placebo * Co had stopped testing the drug to treat heartburn in 2011 * Shares fall 26 pct (Adds comment from conference call, analyst comment; updates share movement) By Vrinda Manocha May 20 (Reuters) - XenoPor

20 May 13 16:25

UPDATE 1-Chief executives and the itch to quit

By Andrew Callus LONDON, May 16 (Reuters) - On approaching his 60th birthday this year, long-serving Tullow Oil boss Aidan Heavey told staff he felt "like two 30 year-olds". A handful of recent shock departures by 50-something chief executives at European blue chip companies - none of

16 May 13 10:28

Chief executives and the itch to quit

By Andrew Callus LONDON, May 16 (Reuters) - On approaching his 60th birthday this year, long-serving Tullow Oil boss Aidan Heavey told staff he felt "like two 30 year-olds". A handful of recent shock departures by 50-something chief executives at European blue chip companies - none of

16 May 13 07:08

Chief executives and the itch to quit

By Andrew Callus LONDON, May 16 (Reuters) - On approaching his 60th birthday this year, long-serving Tullow Oil boss Aidan Heavey told staff he felt "like two 30 year-olds". A handful of recent shock departures by 50-something chief executives at European blue chip companies - none of

16 May 13 07:04

Bristol melanoma drug combo marks new advance in immunotherapy

(For more stories on new cancer data, see ) By Julie Steenhuysen CHICAGO, May 15 (Reuters) - Melanoma patients treated with two Bristol-Myers Squibb drugs fared much better than those who received either of the medications individually, a new advance for treatments that harness the bo

15 May 13 21:59

U.S. STOCKS-Wall St ends near flat after recent highs; healthcare climbs

* Core U.S. retail sales rise 0.5 percent in April * Yum Brands falls as monthly Chinese sales drop * Indexes: Dow down 0.2 pct, S&P flat, Nasdaq up 0.1 pct By Caroline Valetkevitch NEW YORK, May 13 (Reuters) - U.S. stocks closed little changed on Monday, pausing after hit

13 May 13 21:21

US STOCKS-Wall St ends near flat after recent gains; healthcare climbs

* Core U.S. retail sales rise 0.5 percent in April * Yum Brands falls as monthly Chinese sales drop * Indexes: Dow down 0.2 pct, S&P flat, Nasdaq up 0.1 pct By Caroline Valetkevitch NEW YORK, May 13 (Reuters) - U.S. stocks ended flat on Monday, pausing after hitting record

13 May 13 20:42

US STOCKS SNAPSHOT-Wall St pauses for a breather after rally

NEW YORK, May 13 (Reuters) - Wall Street ended little changed on Monday as investors took a breather after indexes hit more record highs last week, but stronger-than-expected retail sales data kept declines in check. The Dow Jones industrial average was down 26.73 points, or 0.18 percent, a

13 May 13 20:07

US STOCKS-Wall St near flat after recent gains; retail data helps

* Core U.S. retail sales rise 0.5 percent in April * Yum Brands falls as monthly Chinese sales drop * Indexes: Dow down 0.2 pct, S&P flat, Nasdaq up 0.1 pct By Caroline Valetkevitch NEW YORK, May 13 (Reuters) - U.S. stocks were little changed on Monday as investors stepped

13 May 13 19:01

US STOCKS-Wall St flat after retail sales, Nasdaq edges higher

* Core U.S. retail sales rise 0.5 percent in April * Yum Brands falls as monthly Chinese sales drop * Crude oil falls, pressuring energy companies * Indexes: Dow down 0.2 pct, S&P up 0.1 pct, Nasdaq up 0.3 pct By Ryan Vlastelica NEW YORK, May 13 (Reuters) - U.S. stoc

13 May 13 16:41

US STOCKS-Wall St dips but rise in retail sales limits decline

* Core U.S. retail sales rise 0.5 percent in April * Yum Brands falls as monthly Chinese sales drop * Crude oil falls, pressuring energy companies * Indexes off: Dow 0.2 pct, S&P 0.1 pct, Nasdaq flat By Ryan Vlastelica NEW YORK, May 13 (Reuters) - U.S. stocks edged l

13 May 13 15:54

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.